A case report of the eradication of pseudomonas aeruginosa from leg ulcer in a patient with essential thrombocythemia

Int J Low Extrem Wounds. 2009 Jun;8(2):117-9. doi: 10.1177/1534734609334811.

Abstract

A patient treated with hydroxyurea had a lower extremity ulcer that was found infected with Pseudomonas aeruginosa. Drug discontinuation and ceftazidime treatment did not initially lead to resolution due to misidentification of inducible betalactamases expressed by the organism and subsequent clinical failure of the cephalosporin in eradicating infection. These class C enzymes may be strongly induced after betalactam exposure and confer resistance to penicillins, cephalosporins, betalactamase inhibitors but not to carbapenems. Though hydroxyurea represents a major cause of essential thrombocythemia-related ulcers, lesion infections by difficult-to-treat organisms should be eradicated to promote wound healing.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Ceftazidime / administration & dosage
  • Ceftazidime / therapeutic use*
  • Dose-Response Relationship, Drug
  • Follow-Up Studies
  • Foot Ulcer / complications*
  • Foot Ulcer / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Pseudomonas Infections / complications
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / isolation & purification*
  • Thrombocytopenia / complications*
  • Thrombocytopenia / drug therapy

Substances

  • Anti-Bacterial Agents
  • Ceftazidime